Breakthrough COVID-19 Infections Were Common in a Bangladeshi Community Cohort
Post-vaccination COVID-19 infection remained frequent in Chandra, Kaliakair, Gazipur, where a community-based cross-sectional survey found that 124 of 300 vaccinated adults reported infection after receiving at least one dose. The cohort’s mean age was 48.0 years, and just over half were male. Even with vaccination in place, infection did not disappear from everyday life; instead, it shifted toward a pattern dominated by mild illness, limited hospitalization, and clear social and clinical correlates.
The study focused on adults aged 18 years and older who had received at least one COVID-19 vaccine dose between March 2021 and December 2022. Investigators used multistage sampling and a pretested semi-structured questionnaire to collect information on demographics, vaccination history, infection after vaccination, preventive practices, comorbidities, and symptom burden. Although the design cannot establish causation, it offers a grounded view of how breakthrough infection behaved in a real community setting rather than in a tightly controlled trial population.
The burden of infection was not trivial.
Among the 124 participants who reported post-vaccination infection, 24 were asymptomatic, 67 had mild disease, 24 had moderate disease, and 9 developed severe disease. Hospitalization remained uncommon, with only 12 infected participants requiring admission. In practical terms, vaccination appears to have preserved a major part of its core clinical value: protection against the worst respiratory outcomes, even when it did not fully block transmission or symptomatic illness.
Risk Concentrated in Rural Residents and People With Diabetes
Multivariable logistic regression identified several factors independently associated with higher odds of post-vaccination infection. Rural residence carried the strongest association, with an adjusted odds ratio of 4.87. Poor mask use was associated with higher odds of infection as well, with an adjusted odds ratio of 2.28. Poor physical distancing carried an adjusted odds ratio of 2.74, while poor hand hygiene was associated with an adjusted odds ratio of 3.61. Diabetes also emerged as a major correlate, with an adjusted odds ratio of 4.46.
These relationships fit the biology of respiratory infection and vaccine protection. Breakthrough infections are more likely when exposure risk remains high, when crowding and inconsistent masking increase inoculum, and when host defense is impaired by metabolic disease. Diabetes can weaken immune responses, prolong inflammation, and make viral illnesses harder to contain at the mucosal and systemic levels. Rural residence may also capture differences in access to timely vaccination, booster uptake, health information, crowding patterns, and ongoing preventive behaviors, all of which can shift the probability of infection in a community setting.
The statistical signal is especially important because it points beyond vaccine status alone. Vaccination reduced risk, but behavior and underlying disease still shaped who became infected.
Booster Doses Separated Higher Protection From Residual Risk
Receipt of a booster dose was protective, with an adjusted odds ratio of 0.23. In a simple clinical reading, that means boosted participants were far less likely to report post-vaccination infection than those without a booster. The result is consistent with the immunologic reality of waning immunity after primary vaccination, especially during periods when immune-evasive variants are circulating and neutralizing antibody levels may no longer be sufficient on their own.
The booster finding matters because it reflects layered protection rather than all-or-nothing immunity. Primary vaccination likely reduced the probability of severe disease, while booster vaccination strengthened defense against infection itself. That combination helps explain why the study found many infections but relatively few severe cases and even fewer hospitalizations. The immune system was not invulnerable, yet it was better prepared to blunt the downstream consequences of infection.
The preprint’s message is therefore operational: vaccination should not be treated as a stand-alone event. Booster uptake appears to have preserved meaningful additional protection in this community sample.
Mild Disease Dominated, But Prevention Still Carried Weight
Clinical severity skewed toward the milder end of the spectrum. More than half of infected participants experienced mild disease, and nearly one in five were asymptomatic. Severe illness occurred, but it was uncommon. This pattern suggests that vaccination did more than simply reduce infection severity in the abstract; it likely shifted the clinical phenotype toward shorter, less dangerous illness in many infected individuals.
Even so, the association with preventive behaviors was clear. Mask use, physical distancing, and hand hygiene all retained independent links to lower infection odds. Those findings argue against a false sense of security after vaccination. In community settings where exposure continues, layered prevention still appears to matter, particularly for people with chronic disease or those living in higher-risk environments.
The data also raise a familiar public health problem: vaccine access and vaccine acceptance may not be enough if prevention practices weaken after rollout. Rural communities may face a different mix of household crowding, mobility, access barriers, and health communication gaps, all of which can erode the real-world benefit of immunization programs.
What This Preprint Adds to the Bangladesh Evidence Base
This community study adds local data from Bangladesh on the prevalence and correlates of breakthrough infection after COVID-19 vaccination. Its strength lies in the fact that it draws from residents rather than a hospital-only sample, capturing infections that might otherwise never reach formal clinical records. The data are also timely because they reflect the period from March 2021 through December 2022, when vaccine coverage, public behavior, and circulating variants were all changing.
The limitations are just as important. The study relied on self-reported infection history and survey responses, which leaves room for recall bias and misclassification. The cross-sectional design cannot determine whether the reported risk factors caused infection or merely traveled with it. The sample size was modest, and the findings came from one locality, so the estimates may not generalize to all Bangladeshi communities or to other countries with different vaccine platforms, variant circulation, and public health infrastructure.
Even with those caveats, the clinical signal is hard to ignore. Breakthrough infection was common, but severe outcomes were uncommon. Booster vaccination, preventive behavior, and diabetes status all shaped the risk profile in ways that align with frontline infectious disease logic. For clinicians and public health teams, the study points toward a familiar but still necessary strategy: keep boosting, keep reinforcing prevention, and pay extra attention to people whose metabolic disease places them at higher risk of infection.